Elysium Bio cell ita
Who We Are
Elysium Cell Bio ITA is an academic spin-off accredited by the University of Naples Federico II, founded on December 1, 2023. It is based at CEINGE Advanced Biotechnology in Naples and is led by a team of researchers specialized in genetics, genomics, and translational research, aiming to transform laboratory discoveries into clinical and commercial applications. The company focuses on the development of innovative diagnostic and therapeutic tools, addressing unmet clinical needs in the fields of virology, oncology, nutraceuticals, and regenerative medicine. The multidisciplinary team works in synergy to accelerate technology transfer and the commercialization of the developed solutions.
MISSION: "FROM IDEA TO MARKET"
Elysium Cell Bio ITA is committed to bridging the gap between academic research and clinical applications, translating scientific discoveries into tangible health solutions. The goal is to provide diagnostic tools, innovative drugs, and natural treatments to improve patients’ quality of life, contributing to innovation in biotechnology and life sciences.
RESEARCH & DEVELOPMENT AREAS
- Molecular Diagnostics and Virology
- Innovative Cancer Therapies and Rigenerative Medicine
- Nutraceutical and Natural Compounds therapies
The Space
Scientific Leadership and Academic Partners
CEO & Founder, expert in Medical Genetics and Molecular Oncology.
Co-Founder, responsible for the development of nutraceutical compounds.
Pediatrics and Nutraceutics
Clinical Infettivology and Virology
Neurologist and Geratrician
Scientific Staff Expert Members
Expert in Marketing and Pharmaceutical Development.
Expert in the “Wound care”, Surgeon and Vulnologist.